Loading...
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
In preclinical models of glioblastoma, antigen escape variants can lead to tumor recurrence after treatment with CAR T cells that are redirected to single tumor antigens. Given the heterogeneous expression of antigens on glioblastomas, we hypothesized that a bispecific CAR molecule would mitigate an...
Saved in:
| Published in: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966331/ https://ncbi.nlm.nih.gov/pubmed/27427982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI83416 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|